Free shipping on all products. Track your order on the Order Status & Details page.
🇦🇺 Australian-Owned Supplier  ·  Kovera Labs reports  ·  Wholesale Pricing

Buy PT-141 in Australia

PT10 (Bremelanotide) — 10mg per vial, box of 10 research-grade vials. MC3R/MC4R selective melanocortin agonist, metabolite of Melanotan II. See published product reports for batch-specific testing information. Australian-owned online supplier. For research use only.

View Products and Pricing Compare with Melanotan II
Research Use Only: All products are for qualified laboratory research purposes only — not for human therapeutic use or consumption. Subject to applicable Australian regulatory requirements.

What Is PT-141?

PT-141 (Bremelanotide) is a cyclic heptapeptide metabolite of Melanotan II, formed via removal of the C-terminal amide group. It acts as a melanocortin receptor agonist with preferential activity at MC3R and MC4R over MC1R — distinguishing it from its parent compound's non-selective receptor profile. This selectivity is the primary research rationale for using PT-141 over Melanotan II when studying MC3R or MC4R-driven pathways in isolation.

Preclinical research has examined PT-141 in sexual function models (MC4R), appetite and energy homeostasis (MC3R/MC4R), and inflammatory response pathways. The reduced MC1R activity means melanogenesis is a less confounding variable in MC3R/MC4R research designs. Eternal Peptides Wholesale stocks both PT-141 (PT10) and Melanotan II (MT10) for comparative receptor research.

For non-selective melanocortin receptor research, see Melanotan II (MT10). For research use only.

PT-141 Products

Supplied as lyophilised powder in boxes of 10 research-grade vials.

PT10

PT-141 (Bremelanotide) 10mg

Box of 10 vials · 10mg per vial

$544.50 per box
  • ✓ Kovera Labs COA published on product page
  • ✓ Review batch-specific test results
  • ✓ Free shipping
  • ✓ Kovera Labs purity, endotoxin, heavy-metal and sterility reports
View full product page + COA
Parent Compound — Non-Selective
Melanotan II — MC1R/MC3R/MC4R/MC5R Agonist
MT10 (10mg) $396.00  ·  Broader receptor profile, melanogenesis research
View Melanotan II

Frequently Asked Questions

Where can I buy PT-141 in Australia? +

Eternal Peptides Wholesale is an Australian-owned, online distributor supplying PT-141 for research purposes. PT10 (10mg, box of 10) is $544.50. Kovera Labs reports, Free shipping. For research use only.

How does PT-141 differ from Melanotan II? +

MT-II activates MC1R, MC3R, MC4R, and MC5R. PT-141 is its metabolite with reduced MC1R affinity, enabling more selective MC3R/MC4R research with less confounding melanogenesis. Both are available from Eternal Peptides Wholesale. See the Melanotan II page. For research use only.

How is PT-141 quality verified? +

Each product page publishes the Kovera Labs reports for its batch. Each report lists the method, stated criterion and result for its batch.

How quickly is PT10 dispatched? +

Consult our Shipping Policy for processing and delivery estimates. Dispatch origin can vary, including offshore fulfilment; Australian business ownership does not guarantee domestic stock or customs-free delivery. Kovera Labs purity, endotoxin, heavy-metal and sterility reports are published on each product page.

Related Research Resources

Parent Compound
Buy Melanotan II Australia
Non-selective alpha-MSH analogue — MT10 pricing.
Popular Compound
Buy BPC-157 Australia
Tissue repair peptide — BC05 & BC10 pricing.
Product Page
PT10 — PT-141 10mg
Kovera Labs report, specifications, and ordering.

Research and buying guide

Testing references updated 1 November 2026 for the published Kovera Labs report set. Original research and catalogue snapshot dates remain as stated.

Kovera Labs testing: purity, endotoxin, heavy metals and sterility

Our listed batches are tested by Kovera Labs, and the reports are published on each product page: HPLC purity and LC-MS identity, endotoxin (EU/mL), heavy metals (lead, arsenic, cadmium and mercury) and sterility (bacteria and fungi), each with a batch number, report ID and a link to the laboratory’s verification record.

How we test: purity, endotoxin, heavy metals and sterility · Kovera Labs COA library · Eternal Peptides Wholesale

For laboratory research use only.

Testing and wholesale procurement: source notes

Product-specific documentation for this guide: PT10: product and report context.

Assess purity separately from peptide quantity. Bachem explains that HPLC purity and net peptide content describe different properties. For a procurement review, start with the published report directory, then match the product, strength and batch to the documents. [1] [2]

Our Kovera Labs reports cover HPLC purity and LC-MS identity, endotoxin (EU/mL), heavy metals (lead, arsenic, cadmium and mercury) and sterility (bacteria and fungi), and each certificate carries its batch number, report ID and a verification link. Results for each tested batch are printed on its product page beside the certificate images. [3] [4] [5]

For wholesale value, compare the same specification and quantity, then check the total payable. The wholesale-price guide explains the method. Products are supplied for laboratory research use only, and TGA requirements apply to research-use supply. [6] [7]

References and bibliography

  1. Bachem. FAQ: analysis of peptides, HPLC purity and net peptide content. Accessed 29 September 2026.
  2. Eternal Peptides Wholesale. Published product-report directory. Accessed 29 September 2026.
  3. Kovera Labs. Sterility testing certificates: results and test conditions. Reports reviewed 1 November 2026; open the individual certificate and its laboratory verification link.
  4. Kovera Labs. Bacterial endotoxin certificates: sample, result, reporting units and limits. Reports reviewed 1 November 2026; open the individual certificate and its laboratory verification link.
  5. Kovera Labs. Heavy-metal certificates: analytes, reporting limits and acceptance criteria. Reports reviewed 1 November 2026; open the individual certificate and its laboratory verification link.
  6. Australian Competition and Consumer Commission. Price displays. Accessed 29 September 2026.
  7. Therapeutic Goods Administration. How we regulate therapeutic peptide products. Accessed 29 September 2026.